Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Tekturna (aliskiren) / PDL

NCT01165983: The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes

Completed

N/A

124

Placebo, Aliskiren, Trade name: Tekturna

Beth Israel Deaconess Medical Center, Novartis Pharmaceuticals

Diabetes Type 2

01/12

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites